Menu
Back to Journals » Biologics: Targets and Therapy » Volume 18 » default
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (502)
- Volume 18, 2024 (6)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 18, 2024
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy
Soberanis Pina P, Lheureux S
Biologics: Targets and Therapy 2024, 18:79-93
Published Date: 21 March 2024
MDMX in Cancer: A Partner of p53 and a p53-Independent Effector
Lin W, Yan Y, Huang Q, Zheng D
Biologics: Targets and Therapy 2024, 18:61-78
Published Date: 31 January 2024
Advances with Platelet-Rich Plasma for Bone Healing
Bacevich BM, Smith RDJ, Reihl AM, Mazzocca AD, Hutchinson ID
Biologics: Targets and Therapy 2024, 18:29-59
Published Date: 25 January 2024
Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing
Asmamaw Mengstie M, Teshome Azezew M, Asmamaw Dejenie T, Teshome AA, Tadele Admasu F, Behaile Teklemariam A, Tilahun Mulu A, Mekonnen Agidew M, Adugna DG, Geremew H, Abebe EC
Biologics: Targets and Therapy 2024, 18:21-28
Published Date: 18 January 2024
Effect of N-Acetylcysteine on Cisplatin Toxicity: A Review of the Literature
Zavala-Valencia AC, Velasco-Hidalgo L, Martínez-Avalos A, Castillejos-López M, Torres-Espíndola LM
Biologics: Targets and Therapy 2024, 18:7-19
Published Date: 16 January 2024
Successful Response to Golimumab in a Case of Relapsing Polychondritis Overlapping with Ulcerative Colitis
Kojima S, Matsumoto S, Koito Y, Miura T, Sekine M, Uehara T, Asano T, Yamaguchi Y, Mashima H
Biologics: Targets and Therapy 2024, 18:1-6
Published Date: 12 January 2024